Bill Text: MI SB0953 | 2023-2024 | 102nd Legislature | Introduced

Michigan Senate Bill 953

Introduced

Bill Title: Health: screening; newborn hearing screening for congenital cytomegalovirus; require. Amends sec. 5431 of 1978 PA 368 (MCL 333.5431) & adds sec. 5433.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2024-06-26 - Referred To Committee On Health Policy [SB0953 Detail]

Download: Michigan-2023-SB0953-Introduced.html

SENATE BILL NO. 953

June 26, 2024, Introduced by Senator MOSS and referred to the Committee on Health Policy.

A bill to amend 1978 PA 368, entitled

"Public health code,"

by amending section 5431 (MCL 333.5431), as amended by 2002 PA 691, and by adding section 5433.

the people of the state of michigan enact:

Sec. 5431. (1) A health professional in charge of the care of a newborn infant or, if none, the health professional in charge at the birth of an infant shall administer or cause to be administered to the infant a test for each of the following:

(a) Phenylketonuria.

(b) Galactosemia.

(d) Maple syrup urine disease.

(e) Biotinidase deficiency.

(f) Sickle cell anemia.

(g) Congenital adrenal hyperplasia.

(h) Medium-chain acyl-coenzyme A dehydrogenase deficiency.

(i) Other treatable but otherwise disabling conditions as designated by the department.

(j) Beginning March 1, 2026, congenital cytomegalovirus.

(2) The informed consent requirements of sections 17020 and 17520 do not apply to the tests required under subsection (1). The tests required under subsection (1) shall must be administered and reported within a time and under conditions prescribed by the department. The department may require that the tests be performed by the department.

(3) If the results of a test administered under subsection (1) (1)(a) to (i) are positive, the results shall must be reported to the infant's parents, guardian, or person in loco parentis. If the results of a test administered under subsection (1)(j) are positive, the results must be reported to the department as required under section 5433 and to the infant's parents, guardian, or person in loco parentis. A person is in compliance with this subsection the requirement to report the results of a test to an infant's parents, guardian, or person in loco parentis if the person makes a good faith good-faith effort to report the positive test results to the infant's parents, guardian, or person in loco parentis.

(4) Subject to the annual adjustment required under this subsection and subject to subsection (6), if the department performs 1 or more of the tests required under subsection (1), the department may charge a fee for the tests of not more than $53.71. The department shall adjust the amount prescribed by this subsection annually by an amount determined by the state treasurer to reflect the cumulative annual percentage change in the Detroit consumer price index. Consumer Price Index. As used in this subsection, "Detroit consumer price index" Consumer Price Index" means the most comprehensive index of consumer prices available for the Detroit area from the bureau of labor statistics Bureau of Labor Statistics of the United States department of labor.Department of Labor.

(5) A person who violates this section or a rule promulgated under this part is guilty of a misdemeanor.

(6) The department shall provide for a hardship waiver of the fee authorized under subsection (4) under circumstances found appropriate by the department.

(7) The department shall do all of the following in regard to the blood specimens taken for purposes of conducting the tests required under subsection (1):

(a) By April 1, 2000, develop a schedule for the retention and disposal of the blood specimens used for the tests after the tests are completed. The schedule shall must meet at least all of the following requirements:

(i) Be consistent with nationally recognized standards for laboratory accreditation and federal law.

(ii) Require that the disposal be conducted in compliance with section 13811.

(iii) Require that the disposal be conducted in the presence of a witness. For purposes of this subparagraph, the witness may be an individual involved in the disposal or any other individual.

(iv) Require that a written record of the disposal be made and kept, and that the witness required under subparagraph (iii) signs the record.

(b) Allow the blood specimens to be used for medical research during the retention period established under subdivision (a), as long as the medical research is conducted in a manner that preserves the confidentiality of the test subjects and is consistent to protect human subjects from research risks under subpart A of part 46 of subchapter A of title 45 of the code of federal regulations.45 CFR 46.101 to 46.124.

(8) The department shall rewrite its pamphlet explaining the requirements of this section when the supply of pamphlets in existence on March 15, 2000 is exhausted. When the department rewrites the explanatory pamphlet, it the department shall include at least all of the following information in the pamphlet:

(a) The nature and purpose of the testing program required under this section, including, but not limited to, a brief description of each condition or disorder listed in subsection (1).

(b) The purpose and value of the infant's parent, guardian, or person in loco parentis retaining a blood specimen obtained under subsection (9) in a safe place.

(d) That the blood specimens taken for purposes of conducting the tests required under subsection (1) may be used for medical research pursuant to subsection (7)(b).

(9) In addition to the requirements of subsection (1), the health professional described in subsection (1) or the hospital or other facility in which the birth of an infant takes place, or both, may offer to draw an additional blood specimen from the infant. If such an offer is made, it shall must be made to the infant's parent, guardian, or person in loco parentis at the time the blood specimens are drawn for purposes of subsection (1). If the infant's parent, guardian, or person in loco parentis accepts the offer of an additional blood specimen, the blood specimen shall must be preserved in a manner that does not require special storage conditions or techniques, including, but not limited to, lamination. The health professional or hospital or other facility employee making the offer shall explain to the parent, guardian, or person in loco parentis at the time the offer is made that the additional blood specimen can be used for future identification purposes and should be kept in a safe place. The health professional or hospital or other facility making the offer may charge a fee that is not more than the actual cost of obtaining and preserving the additional blood specimen.

(10) The test described in subsection (1)(j) must be administered by a blood spot, saliva, or urine specimen test or by another test for congenital cytomegalovirus that is diagnostically equivalent as determined by the department.

Sec. 5433. (1) If the results of a test under section 5431(1)(j) are positive, the health professional in charge of the care of the newborn infant or, if none, the health professional in charge at the birth of the infant, the hospital, the local health department, or other facility shall do both of the following:

(a) Provide the parent, guardian, or person in loco parentis of the infant with the information described in subsection (2) and information on available methods of treatment for cCMV.

(b) Report to the department, on a form prescribed by the department, the results of the test.

(2) The department shall develop and implement a public education program on CMV and cCMV to provide information to pregnant women and women who may become pregnant on all of the following:

(a) The incidence of CMV and cCMV.

(b) The transmission of CMV to pregnant women and women who may become pregnant.

(d) Methods of diagnosing cCMV.

(e) Available preventative measures to avoid the infection of women who are pregnant or may become pregnant.

(3) The department shall post the information described in subsection (2) on its website and provide the information to all of the following:

(a) A child care program.

(b) An individual serving as a school nurse.

(d) A health professional, hospital, local health department, or other facility that offers care to pregnant women or infants.

(4) As used in this section:

(a) "Child care program" means a child care center, group child care home, or family child care home licensed under 1973 PA 116, MCL 722.111 to 722.128.

(b) "CMV" means cytomegalovirus.